Time course and progression of wild type α-Synuclein accumulation in a transgenic mouse model

<p>Abstract</p> <p>Background</p> <p>Progressive accumulation of α-synuclein (α-Syn) protein in different brain regions is a hallmark of synucleinopathic diseases, such as Parkinson’s disease, dementia with Lewy bodies and multiple system atrophy. α-Syn transgenic mouse...

Full description

Bibliographic Details
Main Authors: Amschl David, Neddens Jörg, Havas Daniel, Flunkert Stefanie, Rabl Roland, Römer Heinrich, Rockenstein Edward, Masliah Eliezer, Windisch Manfred, Hutter-Paier Birgit
Format: Article
Language:English
Published: BMC 2013-01-01
Series:BMC Neuroscience
Subjects:
Online Access:http://www.biomedcentral.com/1471-2202/14/6
id doaj-8e41c919872147e196633664c57597ac
record_format Article
spelling doaj-8e41c919872147e196633664c57597ac2020-11-24T22:06:26ZengBMCBMC Neuroscience1471-22022013-01-01141610.1186/1471-2202-14-6Time course and progression of wild type α-Synuclein accumulation in a transgenic mouse modelAmschl DavidNeddens JörgHavas DanielFlunkert StefanieRabl RolandRömer HeinrichRockenstein EdwardMasliah EliezerWindisch ManfredHutter-Paier Birgit<p>Abstract</p> <p>Background</p> <p>Progressive accumulation of α-synuclein (α-Syn) protein in different brain regions is a hallmark of synucleinopathic diseases, such as Parkinson’s disease, dementia with Lewy bodies and multiple system atrophy. α-Syn transgenic mouse models have been developed to investigate the effects of α-Syn accumulation on behavioral deficits and neuropathology. However, the onset and progression of pathology in α-Syn transgenic mice have not been fully characterized. For this purpose we investigated the time course of behavioral deficits and neuropathology in PDGF-β human wild type α-Syn transgenic mice (D-Line) between 3 and 12 months of age.</p> <p>Results</p> <p>These mice showed progressive impairment of motor coordination of the limbs that resulted in significant differences compared to non-transgenic littermates at 9 and 12 months of age. Biochemical and immunohistological analyses revealed constantly increasing levels of human α-Syn in different brain areas. Human α-Syn was expressed particularly in somata and neurites of a subset of neocortical and limbic system neurons. Most of these neurons showed immunoreactivity for phosphorylated human α-Syn confined to nuclei and perinuclear cytoplasm. Analyses of the phenotype of α-Syn expressing cells revealed strong expression in dopaminergic olfactory bulb neurons, subsets of GABAergic interneurons and glutamatergic principal cells throughout the telencephalon. We also found human α-Syn expression in immature neurons of both the ventricular zone and the rostral migratory stream, but not in the dentate gyrus.</p> <p>Conclusion</p> <p>The present study demonstrates that the PDGF-β α-Syn transgenic mouse model presents with early and progressive accumulation of human α-Syn that is accompanied by motor deficits. This information is essential for the design of therapeutical studies of synucleinopathies.</p> http://www.biomedcentral.com/1471-2202/14/6BehaviorImmunofluorescenceMotor deficitMouse modelParkinson’s diseasePhosphorylationSynucleinopathyα-SynucleinTransgene
collection DOAJ
language English
format Article
sources DOAJ
author Amschl David
Neddens Jörg
Havas Daniel
Flunkert Stefanie
Rabl Roland
Römer Heinrich
Rockenstein Edward
Masliah Eliezer
Windisch Manfred
Hutter-Paier Birgit
spellingShingle Amschl David
Neddens Jörg
Havas Daniel
Flunkert Stefanie
Rabl Roland
Römer Heinrich
Rockenstein Edward
Masliah Eliezer
Windisch Manfred
Hutter-Paier Birgit
Time course and progression of wild type α-Synuclein accumulation in a transgenic mouse model
BMC Neuroscience
Behavior
Immunofluorescence
Motor deficit
Mouse model
Parkinson’s disease
Phosphorylation
Synucleinopathy
α-Synuclein
Transgene
author_facet Amschl David
Neddens Jörg
Havas Daniel
Flunkert Stefanie
Rabl Roland
Römer Heinrich
Rockenstein Edward
Masliah Eliezer
Windisch Manfred
Hutter-Paier Birgit
author_sort Amschl David
title Time course and progression of wild type α-Synuclein accumulation in a transgenic mouse model
title_short Time course and progression of wild type α-Synuclein accumulation in a transgenic mouse model
title_full Time course and progression of wild type α-Synuclein accumulation in a transgenic mouse model
title_fullStr Time course and progression of wild type α-Synuclein accumulation in a transgenic mouse model
title_full_unstemmed Time course and progression of wild type α-Synuclein accumulation in a transgenic mouse model
title_sort time course and progression of wild type α-synuclein accumulation in a transgenic mouse model
publisher BMC
series BMC Neuroscience
issn 1471-2202
publishDate 2013-01-01
description <p>Abstract</p> <p>Background</p> <p>Progressive accumulation of α-synuclein (α-Syn) protein in different brain regions is a hallmark of synucleinopathic diseases, such as Parkinson’s disease, dementia with Lewy bodies and multiple system atrophy. α-Syn transgenic mouse models have been developed to investigate the effects of α-Syn accumulation on behavioral deficits and neuropathology. However, the onset and progression of pathology in α-Syn transgenic mice have not been fully characterized. For this purpose we investigated the time course of behavioral deficits and neuropathology in PDGF-β human wild type α-Syn transgenic mice (D-Line) between 3 and 12 months of age.</p> <p>Results</p> <p>These mice showed progressive impairment of motor coordination of the limbs that resulted in significant differences compared to non-transgenic littermates at 9 and 12 months of age. Biochemical and immunohistological analyses revealed constantly increasing levels of human α-Syn in different brain areas. Human α-Syn was expressed particularly in somata and neurites of a subset of neocortical and limbic system neurons. Most of these neurons showed immunoreactivity for phosphorylated human α-Syn confined to nuclei and perinuclear cytoplasm. Analyses of the phenotype of α-Syn expressing cells revealed strong expression in dopaminergic olfactory bulb neurons, subsets of GABAergic interneurons and glutamatergic principal cells throughout the telencephalon. We also found human α-Syn expression in immature neurons of both the ventricular zone and the rostral migratory stream, but not in the dentate gyrus.</p> <p>Conclusion</p> <p>The present study demonstrates that the PDGF-β α-Syn transgenic mouse model presents with early and progressive accumulation of human α-Syn that is accompanied by motor deficits. This information is essential for the design of therapeutical studies of synucleinopathies.</p>
topic Behavior
Immunofluorescence
Motor deficit
Mouse model
Parkinson’s disease
Phosphorylation
Synucleinopathy
α-Synuclein
Transgene
url http://www.biomedcentral.com/1471-2202/14/6
work_keys_str_mv AT amschldavid timecourseandprogressionofwildtypeasynucleinaccumulationinatransgenicmousemodel
AT neddensjorg timecourseandprogressionofwildtypeasynucleinaccumulationinatransgenicmousemodel
AT havasdaniel timecourseandprogressionofwildtypeasynucleinaccumulationinatransgenicmousemodel
AT flunkertstefanie timecourseandprogressionofwildtypeasynucleinaccumulationinatransgenicmousemodel
AT rablroland timecourseandprogressionofwildtypeasynucleinaccumulationinatransgenicmousemodel
AT romerheinrich timecourseandprogressionofwildtypeasynucleinaccumulationinatransgenicmousemodel
AT rockensteinedward timecourseandprogressionofwildtypeasynucleinaccumulationinatransgenicmousemodel
AT masliaheliezer timecourseandprogressionofwildtypeasynucleinaccumulationinatransgenicmousemodel
AT windischmanfred timecourseandprogressionofwildtypeasynucleinaccumulationinatransgenicmousemodel
AT hutterpaierbirgit timecourseandprogressionofwildtypeasynucleinaccumulationinatransgenicmousemodel
_version_ 1725823796418445312